Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajkumar Savai

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
Nature Communications|May 16, 2019
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertensionSwati Dabral, Christian Muecke, Chanil Valasarajan, et al.
Cancers|January 12, 2021
Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of VersicanDavid Brunn, Kati Turkowski, Stefan Günther, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2011
Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertensionSoni S Pullamsetti, Carmen Doebele, Ariane Fischer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 21, 2009
The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in miceNorbert Weissmann, Sascha Hackemack, Bhola Kumar Dahal, et al.
Cancer Research|August 21, 2020
Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and InflammationNefertiti El-Nikhely, Annika Karger, Poonam Sarode, et al.
Cold Spring Harbor Molecular Case Studies|January 21, 2022
Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case reportMarkus Ball, Petros Christopoulos, Martina Kirchner, et al.
Science Advances|June 18, 2020
Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancerPoonam Sarode, Xiang Zheng, Georgia A Giotopoulou, et al.
Nature Chemical Biology|November 24, 2015
CRISPR-Cas9-based target validation for p53-reactivating model compoundsMichael Wanzel, Jonas B Vischedyk, Miriam P Gittler, et al.
Science Translational Medicine|June 17, 2011
The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosisSoni Savai Pullamsetti, Rajkumar Savai, Rio Dumitrascu, et al.
The Journal of Experimental Medicine|April 25, 2019
Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RETYanhan Jia, Joaquim Si-Long Vong, Alina Asafova, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Nature Communications|May 16, 2019
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertensionSwati Dabral, Christian Muecke, Chanil Valasarajan, et al.
Cancers|January 12, 2021
Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of VersicanDavid Brunn, Kati Turkowski, Stefan Günther, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2011
Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertensionSoni S Pullamsetti, Carmen Doebele, Ariane Fischer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 21, 2009
The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in miceNorbert Weissmann, Sascha Hackemack, Bhola Kumar Dahal, et al.
Cancer Research|August 21, 2020
Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and InflammationNefertiti El-Nikhely, Annika Karger, Poonam Sarode, et al.
Cold Spring Harbor Molecular Case Studies|January 21, 2022
Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case reportMarkus Ball, Petros Christopoulos, Martina Kirchner, et al.
Science Advances|June 18, 2020
Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancerPoonam Sarode, Xiang Zheng, Georgia A Giotopoulou, et al.
Nature Chemical Biology|November 24, 2015
CRISPR-Cas9-based target validation for p53-reactivating model compoundsMichael Wanzel, Jonas B Vischedyk, Miriam P Gittler, et al.
Science Translational Medicine|June 17, 2011
The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosisSoni Savai Pullamsetti, Rajkumar Savai, Rio Dumitrascu, et al.
The Journal of Experimental Medicine|April 25, 2019
Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RETYanhan Jia, Joaquim Si-Long Vong, Alina Asafova, et al.
Pageof 16